548 filings
Page 3 of 28
SC14D9C
4p90vr4vjuv knlej360
1 Nov 22
Written communication relating to third party tender offer
9:27pm
SC TO-C
1ve ppxv55x6ab
1 Nov 22
Information about tender offer
5:25pm
8-K
1fri23lltk7py2rt
1 Nov 22
Abiomed Announces Second Quarter Revenue of $266 Million, Up 11% In Constant Currency*, Up 7% on a Reported Basis Year Over Year
8:14am
SC14D9C
3l3ll lruodersdxvm6
1 Nov 22
Written communication relating to third party tender offer
7:40am
8-K
vk70uhrd4 tsqb
1 Nov 22
Johnson & Johnson to Acquire Abiomed
7:39am
8-K
9cigxf f3zr0
12 Aug 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
qfctttpyrg2gohaor2
4 Aug 22
Results of Operations and Financial Condition
7:14am
DEFA14A
pu67wh5
28 Jun 22
Additional proxy soliciting materials
4:32pm
8-K
zi8 ixpq5lv
21 Jun 22
Other Events
7:12am
SD
r0i21vje
20 May 22
Conflict minerals disclosure
4:10pm
8-K
p1o6k84gvyrdbxg7
28 Apr 22
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, Up 12% Year Over Year
7:30am
8-K
sio3wog6 yjm0kgjl
1 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
drhj0g56lox2ysa15 kn
3 Feb 22
Abiomed Announces Record Revenue of $261 Million, Up 13% Year Over Year
7:19am
8-K
cd30abvk45fmq503
28 Oct 21
Abiomed Announces Q2 Fy 2022 Revenue of $248 Million, Up 18% Year Over Year
7:26am
8-K
h82orxs 0ffxjf8
13 Aug 21
Entry into a Material Definitive Agreement
4:01pm